Natera
NTRA
#689
Rank
โ‚น3.032 T
Marketcap
โ‚น21,969
Share price
1.03%
Change (1 day)
51.17%
Change (1 year)

Revenue for Natera (NTRA)

Revenue in 2025 (TTM): โ‚น183.19 Billion

According to Natera's latest financial reports the company's current revenue (TTM ) is โ‚น190.15 Billion. In 2024 the company made a revenue of โ‚น145.57 Billion an increase over the revenue in the year 2023 that were of โ‚น90.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Natera from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น183.19 B25.84%
2024 โ‚น145.57 B61.53%
2023 โ‚น90.12 B32.78%
2022 โ‚น67.87 B45.79%
2021 โ‚น46.55 B62.81%
2020 โ‚น28.59 B32.64%
2019 โ‚น21.55 B19.67%
2018 โ‚น18.01 B33.51%
2017 โ‚น13.49 B-8.52%
2016 โ‚น14.75 B16.61%
2015 โ‚น12.64 B25.3%
2014 โ‚น10.09 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Prothena
PRTA
โ‚น1.05 B-99.44%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Paratek Pharmaceuticals
PRTK
โ‚น15.06 B-92.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น1.053 T 453.85%๐Ÿ‡บ๐Ÿ‡ธ USA